(Press-News.org) A new cognitive assessment tool with 16 items appears potentially useful for identifying problems in thinking, learning and memory among older adults, according to a report posted online today that will be published in the March 14 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
An estimated 3.4 million older adults in the United States have dementia, and an additional 5.4 million have milder forms of cognitive impairment, according to background information in the article. "For many older adults, cognitive impairment contributes to loss of independence, decreased quality of life and increased health care costs," the authors write. "While the public health impact of cognitive impairment is clear, this condition is often under-recognized. A simple, rapid cognitive assessment instrument is therefore a valuable tool for use in both clinical and research settings."
The most widely known and used measure of cognitive impairment is the Mini-Mental State Examination (MMSE); however, scores on this assessment may be influenced by education level, and the copyright limits its widespread availability. Tamara G. Fong, M.D., Ph.D., of Hebrew SeniorLife, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, and colleagues developed a new instrument called the Sweet 16 to rapidly assess cognitive status in older adults. To develop the questions, the researchers used information from a group of 774 patients who completed the MMSE as part of a screening process for a large randomized trial of a method to decrease delirium. They then validated their results among 709 participants in another study that also used two different dementia and cognitive decline rating scales.
The Sweet 16 scale is scored from zero to 16 (with 16 representing the best score) and includes questions that address orientation (identification of person, place, time and situation), registration, digit spans (tests of verbal memory) and recall. "The Sweet 16 required no pencil, paper or other props and was easy to administer with a minimum of training," the authors write. "In the pilot group, completion time for the instrument ranged from 1.4 to 2.9 minutes, with a mean [average] of 2.0 minutes and a median [midpoint] of 1.9 minutes."
When administered to participants in the validation group, a Sweet 16 score of 14 or less correctly identified 80 percent of the individuals with cognitive impairment (as identified by another questionnaire) and correctly identified 70 percent of those who did not have cognitive impairment. In the same group, the MMSE correctly identified 64 percent of those with cognitive impairment and correctly identified 86 percent of those who were cognitively normal.
The researchers also compared the Sweet 16 to clinicians' diagnoses of cognitive impairment. Sweet 16 scores of 14 or less occurred in 99 percent of patients diagnosed with cognitive impairment and 28 percent of those without such a diagnosis.
"The Sweet 16 could be used in place of other screening measures, such as the MMSE, to rapidly identify cognitive impairments in general clinical practice as well as in research settings," the authors write. "Further studies, including prospective studies to establish the predictive validity of the Sweet 16, to assess test-retest reliability and to compare performance with other brief cognitive measures, are greatly needed. Ultimately, it is hoped that this test will help improve assessment of cognitive function across many settings."
INFORMATION:
(Arch Intern Med. Published online November 8, 2010. doi:10.1001/archinternmed.2010.423. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact Tamara G. Fong, M.D., Ph.D., call Scott Edwards at 781-247-8172 or e-mail edwards@hsl.harvard.edu.
For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.
'Sweet 16' tool may be useful for detecting cognitive impairment
2010-11-09
ELSE PRESS RELEASES FROM THIS DATE:
Improvements within 1 hour of stroke treatment associated with better outcomes
2010-11-09
Patients with stroke who experience improvement within one hour of receiving the clot-dissolving medication tissue plasminogen activator appear more likely to do well three months later, according to a report in the November issue of Archives of Neurology, one of the JAMA/Archives journals.
Only one effective therapy has been approved for acute ischemic stroke (in which blood flow to an area of the brain is blocked or reduced), according to background information in the article. Within 4.5 hours of developing symptoms, patients receive an intravenous (IV) dose of the ...
Vitamins E and C appear to have little effect on age-related cataract
2010-11-09
Long-term, regular use of vitamins E and C has no apparent effect on the risk of age-related cataract in men, according to a report in the November issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
"An estimated 20.5 million persons 40 years and older in the United States show some evidence of age-related cataract," the authors write as background information in the article. "Because oxidative damage is a prominent feature of cataracts, one focus of nutrition research has been the link between dietary intake of nutrients with antioxidant potential, ...
Common corneal condition associated with increased eye pressure
2010-11-09
Corneal arcus, a condition in which a ring of lipids builds up around the cornea, appears common among middle-age and older adults and may be associated with elevated eye pressure, according to a report in the November issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Intraocular pressure (the pressure inside the eye) is the only treatable risk factor for glaucoma, the leading cause of irreversible blindness worldwide, according to background information in the article. "The accuracy of intraocular pressure measurement is crucial in the diagnosis ...
New ocean acidification study shows added danger to already struggling coral reefs
2010-11-09
MIAMI - A new study led by scientists at the University of Miami Rosenstiel School of Marine and Atmospheric Science suggests that over the next century recruitment of new corals could drop by 73 percent, as rising CO2 levels turn the oceans more acidic. The research findings reveal a new danger to the already threatened Caribbean and Florida reef Elkhorn corals.
"Ocean acidification is widely viewed as an emerging threat to coral reefs," said Rosenstiel School graduate student Rebecca Albright. "Our study is one of the first to document the impacts of ocean acidification ...
Solar-powered device affordable, reliable tool to measure blood pressure
2010-11-09
A new solar-powered device to measure blood pressure may help slow the worldwide increase in cardiovascular disease by providing affordable and reliable blood pressure testing in low income countries, according to research published in Hypertension: Journal of the American Heart Association.
The solar powered device — 94 percent in agreement with the standard blood pressure testing method for systolic blood pressure — is in field testing in Uganda and Zambia, Africa.
"The incidence of hypertension is rising dramatically in these countries," said Eoin O'Brien, M.D., ...
Low vitamin D while pregnant or breastfeeding may not be associated with multiple sclerosis relapse
2010-11-09
A small study suggests women with multiple sclerosis have lower vitamin D levels during pregnancy and breastfeeding, according to a report posted online today that will appear in the March 2011 print issue of Archives of Neurology, one of the JAMA/Archives journals. However, these vitamin D levels were not associated with a greater risk of multiple sclerosis relapse after childbirth.
"During the last decade, low level of vitamin D, a potent immunomodulator, has emerged as an important risk factor for multiple sclerosis (MS) as well as other autoimmune diseases and certain ...
Discovery could reveal secrets of ancient Martian and terrestrial atmospheres
2010-11-09
Chemists at UC San Diego have uncovered a new chemical reaction on tiny particulates in the atmosphere that could allow scientists to gain a glimpse from ancient rocks of what the atmospheres of the Earth and Mars were like hundreds of millions years ago.
Their discovery also provides a simple chemical explanation for the unusual carbonate inclusions found in a meteorite from Mars that was once thought by some scientists to be evidence of ancient Martian life.
"We never knew before how the atmosphere could be trapped in carbonate," said Mark Thiemens, dean of UC San ...
New research shows genetic test for lung cancer risk prompts smokers to quit
2010-11-09
Philadelphia – November 8, 2010 – New research shows a gene-based test for lung cancer risk assessment motivates smokers to quit or cut down, according to results of a clinical study presented today at the American Association of Cancer Research's Ninth Annual Conference on Frontiers in Cancer Prevention Research.
Six months after taking the Respiragene test to identify susceptibility for lung cancer risk, 32% of the randomly recruited smokers in the study had quit smoking altogether and a further 48% had reduced their intake of cigarettes. More than half of the smokers ...
Massachusetts Institute of Technology IDs new cancer drug target
2010-11-09
CAMBRIDGE, Mass. -- Suppressing cancer cells' ability to replicate damaged DNA could dramatically enhance the effectiveness of chemotherapy drugs such as cisplatin, according to a new pair of papers from MIT biologists.
In studies of mice, the researchers found that slowing down a specific system for tolerating DNA damage not only prolonged survival but also prevented relapsed tumors from becoming resistant to chemotherapy, and made tumors much less likely to spread to other parts of the body.
Two enzymes that play key roles in a cell's response to DNA damage could ...
Louisiana State University Health Sciences Center research shows fish oil component given up to 5 hours after stroke limits brain damage
2010-11-09
New Orleans, LA – Research led by Dr. Nicolas Bazan, Boyd Professor, Villere Chair, and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center, has shown that Docosahexaenoic acid (DHA), a component of fish oil, is a powerful therapeutic agent that can protect brain tissue and promote recovery in an experimental model of acute ischemic stroke, even when treatment is delayed by up to five hours. These findings not only target a new stroke treatment approach, but also provide vital information about the length of the therapeutic window. The NIH-funded ...